When are laboratory tests indicated in patients with vitiligo?

Dermato-Endocrinology

Volumn 4, Issue 1, 2012, Pages 53-57

  Rodríguez Martín, Marina ^a   Sáez, Miguel ^a   De Paz, Nayra Merino ^a   Ferrer, Patricia Contreras ^a   Eliche, Mar Pestana ^a   Rodríguez Martín, Beatriz ^a   Cabrera, Antonio Noda ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; PARIETAL CELL ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DEMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SPAIN; STATISTICAL ANALYSIS; THYROID FUNCTION; VITILIGO;

EID: 84863652352     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.19200     Document Type: Article

References (14)

1. Rodríguez-Martín M, García Bustínduy M, Sáez Rodríguez M, Noda Cabrera A. Randomized, doubleblind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. Br J Dermatol 2009; 160:409-14; PMID:19016706; http://dx.doi.org/10. 1111/j.1365-2133.2008.08906.x
2. Balci DD, Yonden Z, Yenin JZ, Okumus N. Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. Eur J Dermatol 2009; 19:382-3; PMID:19451048
3. Taïeb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20:27-35; PMID:17250545; http://dx.doi.org/10.1111/ j.1600-0749.2006.00355.x
4. Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82:369-72; PMID:12430737; http://dx.doi.org/10. 1080/000155502320624113
5. Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Immunoprecipitation of melanogenic enzyme auto-antigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 1997; 109: 495-500; PMID:9328128; http://dx.doi.org/10.1046/ j.1365-2249.1997.4781381.x
6. Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993; 100:812-5; PMID:8496621; http://dx.doi.org/10. 1111/ 1523-1747.ep12476636
7. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97:1078-80; PMID:1748818; http://dx.doi.org/10. 1111/1523-1747.ep12492607
8. Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988; 118:223-8; PMID:3348967; http://dx.doi.org/10. 1111/j.1365- 2133.1988.tb01778.x
9. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists, Clinical Standards Department, Royal College of Physicians of London, Cochrane Skin Group, Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051-76; PMID:19036036; http://dx.doi.org/10. 1111/j.1365-2133.2008.08881.x
10. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. J Dermatol Sci 2006; 41:3-10; PMID:16289692; http://dx.doi.org/10. 1016/ j.jdermsci.2005.10.001
11. Grunnet I, Howitz J, Reymann F, Schwartz M. Vitiligo and pernicious anemia. Arch Dermatol 1970; 101:82-5; PMID:5416800; http://dx.doi.org/10.1001/ archderm. 1970.04000010084015
12. Gauthier Y, Cario Andre M, Taïeb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16:322- 32; PMID:12859615; http://dx.doi.org/10.1034/j. 1600-0749.2003.00070.x
13. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999; 26:653-7; PMID:10554431
14. Kurtev A, Dourmishev AL. Thyroid function and autoimmunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venereol 2004; 18:109-11; PMID:14678552; http://dx.doi.org/10.1111/j.1468- 3083.2004.00728.x